Article Details
Retrieved on: 2025-03-12 00:43:52
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the launch of ACCRUFeR®, an oral prescription medication, in Canada by Shield Therapeutics in partnership with KYE Pharmaceuticals. This addresses iron deficiency anemia, a public health concern reflected in the tags and key concept.
Article found on: www.investegate.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here